Does RANIBIZUMAB Cause Inflammation? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Inflammation have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.2% of all adverse event reports for RANIBIZUMAB.
37
Reports of Inflammation with RANIBIZUMAB
0.2%
of all RANIBIZUMAB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Inflammation From RANIBIZUMAB?
Of the 37 reports, 1 (2.7%) resulted in death, 3 (8.1%) required hospitalization.
Is Inflammation Listed in the Official Label?
Yes, Inflammation is listed as a known adverse reaction in the official FDA drug label for RANIBIZUMAB.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Inflammation?
ADALIMUMAB (7,754)
METHOTREXATE (5,055)
ETANERCEPT (4,459)
RITUXIMAB (3,540)
SECUKINUMAB (3,515)
INFLIXIMAB (3,448)
TOCILIZUMAB (3,371)
ABATACEPT (3,284)
TOFACITINIB (3,241)
LEFLUNOMIDE (3,067)
Which RANIBIZUMAB Alternatives Have Lower Inflammation Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE